-transparent.png){kind=logo}
We report the cases of two patients fulfilling DSM-IV criteria for schizophrenia, who developed a marked depressive symptomatology in the first period of a treatment with clozapine, and were treated successfully with serotonergic drugs (paroxetine, clomipramine). The AA. discuss the possible neurochemical determinants and implications of these clinical observations.
Related Publications
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
August 1996,
Journal of clinical psychopharmacology,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
March 2020,
Asian journal of psychiatry,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
March 2007,
Progress in neuro-psychopharmacology & biological psychiatry,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
January 2009,
Clinical drug investigation,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
December 1989,
Journal of abnormal child psychology,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
September 2020,
International clinical psychopharmacology,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
February 2003,
Kardiologia polska,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
July 1983,
International endodontic journal,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
January 1995,
Behavioural neurology,
A C Altamura, and
S Bignotti, and
G Tura, and
R Curreli, and
R Pioli
July 2006,
Medicina oral, patologia oral y cirugia bucal,
